Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03769103
Title Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

lung non-small cell carcinoma

Therapies

Osimertinib

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.